Overview

Study of MAR001 in Adults With Metabolic Dysfunction

Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of multiple doses of MAR001in adult volunteers with metabolic dysfunction.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Marea Therapeutics